Gdansk, 15.09.

2020

ANALYSIS REPORT No S/CL/758/20

Kannaway Europe B.V
Customer
Singiel 250 1016 AB Amsterdam The Netherlands

Basis for analysis Subject of analysis Condition of samples

correct / incorrect - according
order number, contract number sample matrix
to
I-01/PO-03 instruction
Z/CL/758/20 Vaping Liquid Correct

Place of sampling Date of sampling

Date of samples’ Analysis completion
according to the Customer's delivery to the laboratory date
according to the Customer's information
information
No data No data 11.09.2020 15.09.2020

Analyses conducted by: Additional information

EkotechLAB R&D Laboratory Fiszera 14, 80-231 Gdańsk, Poland None

Samples identification:
No. Sample labeling by Customer Sample labeling by Laboratory
Kannaway Hemp + Vape Active 300 mg, LOT:26212, Production
1. CLO 1680/20
date: 10.09.2020, Expiration date: 10.03.2022

Results:
Subject of
No. Sample code Method* Result *** [% (m/m)] mg/9,7g
determination
1. CBD PB-CL-1:2019 issue.3 from 26.08.2020/HPLC/NA 30.98 300.51
2. CBDA PB-CL-1:2019 issue.3 from 26.08.2020/HPLC/NA 0.02 0.19
3. delta-9-THC PB-CL-1:2019 issue.3 from 26.08.2020/HPLC/NA <0.01 N/ A
4. delta-9-THCA PB-CL-1:2019 issue.3 from 26.08.2020/HPLC/NA <0.01 N/A
5. CBC PB-CL-1:2019 issue.3 from 26.08.2020/HPLC/NA <0.01 N/A
6. CBGA PB-CL-1:2019 issue.3 from 26.08.2020/HPLC/NA <0.01 N/A
7. CLO 1680/20 CBG PB-CL-1:2019 issue.3 from 26.08.2020/HPLC/NA 0.06 0.58
8. CBDV PB-CL-1:2019 issue.3 from 26.08.2020/HPLC/NA 0.43 4.17
9. CBN PB-CL-1:2019 issue.3 from 26.08.2020/HPLC/NA <0.01 N/A
10. Sum of CBD PB-CL-1:2019 issue.3 from 26.08.2020/HPLC/NA 31.00 300.70
Sum of delta-9-
11. PB-CL-1:2019 issue.3 from 26.08.2020/HPLC/NA <0.01 N/A
THC
Sum of
12. PB-CL-1:2019 issue.3 from 26.08.2020/HPLC/NA 31.49 305.45
cannabinoids
The method No. assigned according to the formula: No. of test procedure / issue / date issued / analytical technique / A - accredited, NA - not
* accredited, P - performed by the subcontractor

THE END OF REPORT

Form F-02/PO-03 Valid since 2020.08.28